NO994511D0 - Farmasöytiske kombinerte preparater inneholdende erythropoietin og jern-preparater - Google Patents

Farmasöytiske kombinerte preparater inneholdende erythropoietin og jern-preparater

Info

Publication number
NO994511D0
NO994511D0 NO994511A NO994511A NO994511D0 NO 994511 D0 NO994511 D0 NO 994511D0 NO 994511 A NO994511 A NO 994511A NO 994511 A NO994511 A NO 994511A NO 994511 D0 NO994511 D0 NO 994511D0
Authority
NO
Norway
Prior art keywords
preparations
iron
containing erythropoietin
pharmaceutical combined
preparations containing
Prior art date
Application number
NO994511A
Other languages
English (en)
Other versions
NO994511L (no
NO324661B1 (no
Inventor
Paul Lehmann
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Priority to NO19994511A priority Critical patent/NO324661B1/no
Publication of NO994511D0 publication Critical patent/NO994511D0/no
Publication of NO994511L publication Critical patent/NO994511L/no
Publication of NO324661B1 publication Critical patent/NO324661B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Clamps And Clips (AREA)
NO19994511A 1997-03-18 1999-09-17 Anvendelse av lav-dose erytropoietinpreparater og et fysiologisk forenlig lav-dose jernpreparat for fremstilling av et farmasoytisk kombinasjonspreparat for behandling av hemodialyse-pasienter eller for behandling av anemi NO324661B1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO19994511A NO324661B1 (no) 1997-03-18 1999-09-17 Anvendelse av lav-dose erytropoietinpreparater og et fysiologisk forenlig lav-dose jernpreparat for fremstilling av et farmasoytisk kombinasjonspreparat for behandling av hemodialyse-pasienter eller for behandling av anemi

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP1997/001343 WO1998041226A1 (de) 1997-03-18 1997-03-18 Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate
NO19994511A NO324661B1 (no) 1997-03-18 1999-09-17 Anvendelse av lav-dose erytropoietinpreparater og et fysiologisk forenlig lav-dose jernpreparat for fremstilling av et farmasoytisk kombinasjonspreparat for behandling av hemodialyse-pasienter eller for behandling av anemi

Publications (3)

Publication Number Publication Date
NO994511D0 true NO994511D0 (no) 1999-09-17
NO994511L NO994511L (no) 1999-09-17
NO324661B1 NO324661B1 (no) 2007-11-26

Family

ID=8166555

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994511A NO324661B1 (no) 1997-03-18 1999-09-17 Anvendelse av lav-dose erytropoietinpreparater og et fysiologisk forenlig lav-dose jernpreparat for fremstilling av et farmasoytisk kombinasjonspreparat for behandling av hemodialyse-pasienter eller for behandling av anemi

Country Status (19)

Country Link
US (1) US6710028B2 (no)
EP (1) EP0977582B1 (no)
JP (1) JP2000514092A (no)
AT (1) ATE222118T1 (no)
AU (1) AU726801B2 (no)
BR (1) BR9714632A (no)
CA (1) CA2284910C (no)
CZ (1) CZ296960B6 (no)
DE (1) DE59707988D1 (no)
DK (1) DK0977582T3 (no)
ES (1) ES2180958T3 (no)
HU (1) HU226204B1 (no)
IL (2) IL131959A0 (no)
NO (1) NO324661B1 (no)
NZ (1) NZ337465A (no)
PL (1) PL187479B1 (no)
PT (1) PT977582E (no)
SI (1) SI0977582T1 (no)
WO (1) WO1998041226A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7304150B1 (en) 1998-10-23 2007-12-04 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
US7459435B2 (en) 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US20040198663A1 (en) * 2003-04-04 2004-10-07 Baker John E. Method of treating cardiac ischemia by using erythropoietin
WO2005000340A1 (en) * 2003-06-27 2005-01-06 Pomytkin Igor A Synergistic compositions comprising erythropoietin and succinic acid (salt)
CN1901934B (zh) * 2003-12-19 2013-09-11 弗·哈夫曼-拉罗切有限公司 促红细胞生成素在治疗慢性炎症性肠病中铁分布紊乱中的用途
US20080090765A1 (en) * 2006-05-25 2008-04-17 The Trustees Of Columbia University In The City Of New York Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
EP2219602A1 (en) * 2007-11-15 2010-08-25 Amgen, Inc Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
EP2067752A1 (en) * 2007-12-06 2009-06-10 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Construction material
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
WO2011149962A1 (en) 2010-05-24 2011-12-01 The Trustees Of Columbia University In The City Of New York Mutant ngal proteins and uses thereof
WO2014081980A2 (en) 2012-11-21 2014-05-30 The Trustees Of Columbia University In The City Of New York Mutant ngal proteins and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst AND sequence encoding human erythropoietin, a process for its preparation and a pharmacological preparation of human erythropoietin
US4745099A (en) * 1985-02-06 1988-05-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of malignant tumors
NO881507D0 (no) * 1987-04-10 1988-04-07 Ortho Pharma Corp Fremgangsmaate for forhoeyning av hematokritnivaaet til et normalt pattedyr.
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
DE19535571A1 (de) * 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
EP0885613A1 (de) * 1997-06-21 1998-12-23 Roche Diagnostics GmbH Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
US20020065214A1 (en) * 2000-11-29 2002-05-30 Adrian Iaina Method of treating congestive heart failure
ES2361824T3 (es) * 2000-12-20 2011-06-22 F. Hoffmann-La Roche Ag Conjugados de eritropoyetina (epo) con polietilenglicol (peg).

Also Published As

Publication number Publication date
EP0977582B1 (de) 2002-08-14
CZ296960B6 (cs) 2006-08-16
HUP0001409A3 (en) 2003-08-28
IL131959A (en) 2006-12-31
ATE222118T1 (de) 2002-08-15
ES2180958T3 (es) 2003-02-16
EP0977582A1 (de) 2000-02-09
CZ9903300A3 (cs) 2001-03-14
PL187479B1 (pl) 2004-07-30
BR9714632A (pt) 2000-05-23
WO1998041226A9 (de) 1999-11-25
CA2284910C (en) 2003-01-28
US6710028B2 (en) 2004-03-23
US20020094948A1 (en) 2002-07-18
DE59707988D1 (de) 2002-09-19
AU2157297A (en) 1998-10-12
CA2284910A1 (en) 1998-09-24
AU726801B2 (en) 2000-11-23
JP2000514092A (ja) 2000-10-24
NO994511L (no) 1999-09-17
NZ337465A (en) 2002-04-26
NO324661B1 (no) 2007-11-26
HU226204B1 (en) 2008-06-30
PT977582E (pt) 2002-12-31
SI0977582T1 (en) 2002-12-31
IL131959A0 (en) 2001-03-19
PL335858A1 (en) 2000-05-22
WO1998041226A1 (de) 1998-09-24
HUP0001409A2 (en) 2001-03-28
DK0977582T3 (da) 2002-12-16

Similar Documents

Publication Publication Date Title
CA2234282A1 (en) Drug-resin complexes stabilized by chelating agents
HK1001834A1 (en) Stable ascorbic acid compositions
NO981136D0 (no) Farmasöytiske kombinasjonspreparater inneholdende erytropoietin og jernpreparater
ATE104380T1 (de) Sauerstoffdelignifizierung und enzymatische behandlung.
NO994511L (no) Farmasöytiske kombinerte preparater inneholdende erythropoietin og jern-preparater
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
NO944764L (no) Inklusjonskomplekser i vandige opplösninger av benzotiofenforbindelser med vannopplöselige cyklodekstriner og farmasöytiske formuleringer og fremgangsmåter
AU2001287850A1 (en) Iron compositions
DK0996462T3 (da) Farmaceutiske kombinationspræparater indeholdende erythropoietin og modificerede hæmoglobiner
AU6010696A (en) Iron compounds, compositions, methods of making the same and uses thereof
ATE232243T1 (de) Reduktion von eisenoxyd im drehherdofen
KR960013376A (ko) 철과 디프룩토오스를 함유하는 빈혈치료제
PL322763A1 (en) Levobupivacaine and pplication thereof as anelgetic agent for pregnant women
WO1991015466A3 (en) Aminopolycarboxylic acid chelating agents
HU912742D0 (en) T-pa pro-stabilization
TR199902305T2 (xx) Eritropoitein ve demir preperasyonları içeren farmasötik birleşimli preperasyonlar.
SU1828577A3 (ru) Состав, стимулирующий лейкопоэз
BG94567A (en) Medicaments for the treatment of aids and method for its application
UA10825A (uk) Протимікробhий засіб
MX9705119A (es) Interferona modificada quimicamente.

Legal Events

Date Code Title Description
MK1K Patent expired